ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,407, issued on Feb. 10, was assigned to FibroBiologics Inc. (Houston).
"Fibroblast cell therapy for treatment of osteoporosis" was invented by Pete O'Heeron (Houston) and Thomas Ichim (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the disclosure include methods and compositions related to modulation of bone using particular fibroblasts. The modulation includes reducing osteoclast activity and/or activation and/or stimulating osteoblast activity. In particular cases, bone is modulated in an individual with a bone condition, such as osteoporosis. Particular fibroblasts may be delivered to reduce inflammatory cytokine producti...